S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:CTV

Innovid (CTV) Stock Price, News & Analysis

$2.21
-0.16 (-6.75%)
(As of 05:36 PM ET)
Today's Range
$2.19
$2.35
50-Day Range
$1.46
$2.49
52-Week Range
$0.85
$2.58
Volume
88,215 shs
Average Volume
281,391 shs
Market Capitalization
$313.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.45

Innovid MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
10.9% Upside
$2.45 Price Target
Short Interest
Healthy
0.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.78mentions of Innovid in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$66,020 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.97 out of 5 stars

Computer And Technology Sector

557th out of 585 stocks

Prepackaged Software Industry

190th out of 197 stocks

CTV stock logo

About Innovid Stock (NYSE:CTV)

Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.

CTV Stock Price History

CTV Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Reviewing Innovid (NYSE:CTV) & Global-E Online (NASDAQ:GLBE)
Innovid Corp. (CTV)
Innovid Corp. (CTV) Q4 2023 Earnings Call Transcript
Innovid Corp. (NYSE:CTV) Q4 2023 Earnings Call Transcript
Innovid to Participate in Upcoming Investor Conferences
Innovid to Participate in Upcoming Investor Conferences
Innovid’s Strong Financials and Market Positioning Garner Buy Rating
Innovid Corp. Q4 loss drops in line with estimates
Innovid Clears Breakeven on Quarterly Results
Innovid Reports Q4 and Fiscal Year 2023 Financial Results
A Preview Of Innovid's Earnings
See More Headlines
Receive CTV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovid and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/19/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
466
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.45
High Stock Price Target
$3.00
Low Stock Price Target
$2.10
Potential Upside/Downside
+3.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-31,910,000.00
Pretax Margin
-21.12%

Debt

Sales & Book Value

Annual Sales
$139.88 million
Cash Flow
$0.05 per share
Book Value
$1.39 per share

Miscellaneous

Free Float
127,783,000
Market Cap
$336.11 million
Optionable
Not Optionable
Beta
3.31
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Prof. Zvika Netter (Age 51)
    Co-Founder, CEO & Chair of the Board
    Comp: $749.87k
  • Ms. Tanya Andreev-Kaspin (Age 46)
    Executive Officer
    Comp: $575.13k
  • Mr. Anthony Callini (Age 52)
    Chief Financial Officer
  • Mr. Kenneth Markus (Age 49)
    Chief Operating Officer
  • Mr. Yuval Pemper (Age 53)
    Chief Technology Officer
  • John T. Williams
    Head of Investor Relations
  • Mr. Stephen Cook
    General Counsel
  • Ms. Dani Cushion (Age 46)
    Chief Marketing Officer
  • Ms. Liel Golan
    Senior Vice President of Human Resources
  • Ms. Michal Livny
    Senior Vice President of People Operations

CTV Stock Analysis - Frequently Asked Questions

Should I buy or sell Innovid stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Innovid in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTV shares.
View CTV analyst ratings
or view top-rated stocks.

What is Innovid's stock price target for 2024?

3 Wall Street analysts have issued 12-month target prices for Innovid's shares. Their CTV share price targets range from $2.10 to $3.00. On average, they predict the company's stock price to reach $2.45 in the next year. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for CTV
or view top-rated stocks among Wall Street analysts.

How have CTV shares performed in 2024?

Innovid's stock was trading at $1.50 at the start of the year. Since then, CTV stock has increased by 47.3% and is now trading at $2.21.
View the best growth stocks for 2024 here
.

Are investors shorting Innovid?

Innovid saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 338,800 shares, an increase of 14.1% from the March 15th total of 296,900 shares. Based on an average daily volume of 291,700 shares, the short-interest ratio is currently 1.2 days. Currently, 0.4% of the company's shares are sold short.
View Innovid's Short Interest
.

When is Innovid's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our CTV earnings forecast
.

How can I listen to Innovid's earnings call?

Innovid will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Innovid's earnings last quarter?

Innovid Corp. (NYSE:CTV) announced its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The firm earned $38.62 million during the quarter, compared to analysts' expectations of $36.90 million. Innovid had a negative net margin of 22.81% and a negative trailing twelve-month return on equity of 8.92%. During the same quarter in the prior year, the business posted ($0.03) EPS.

What guidance has Innovid issued on next quarter's earnings?

Innovid updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $34.0 million-$36.0 million, compared to the consensus revenue estimate of $33.1 million.

How do I buy shares of Innovid?

Shares of CTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CTV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners